Yantai Zhenghai Bio-tech (300653.SZ): The policy of centralized procurement of dental implants has been fully implemented for more than a year, and the overall cost of a single conventional dental implant has been greatly reduced.

Gelonghui Finance · Aug 8 03:15

Yantai Zhenghai Bio-Tech (300653.SZ) stated during an investor relations event on August 8th that as of April 2024, the collective purchase policy for dental implants has been fully implemented for over a year, and the overall cost of conventional single dental implants has been greatly reduced, significantly alleviating the medical burden on patients. With the implementation of the procurement policy, the price difference between public and private dental medical institutions has narrowed, and competition in the private dental industry has become increasingly fierce. Although implant restoration materials are not included in the procurement scope, they are also affected by demand fluctuations and downstream cost reductions. In the first half of the year, the company optimized its marketing strategy and actively expanded the market for dental-related products in the field of implantation, achieving certain results in terms of market share and sales growth year-on-year. It is expected that with the further implementation of the strategy in the future, the effect will gradually become apparent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

正海生物(300653.SZ)：种植牙集采政策全面执行已逾一年，单颗常规口腔种植牙的整体费用大大降低

Yantai Zhenghai Bio-tech (300653.SZ): The policy of centralized procurement of dental implants has been fully implemented for more than a year, and the overall cost of a single conventional dental implant has been greatly reduced.

Risk Disclaimer

Statement